OTC Markets OTCQB - Delayed Quote USD

Algernon Pharmaceuticals Inc. (AGNPF)

Compare
0.0600
0.0000
(0.00%)
As of April 15 at 4:00:00 PM EDT. Market Open.
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
8/31/2024
8/31/2023
8/31/2022
8/31/2021
Operating Expense
2,271.3910
2,412.0420
5,241.9910
6,019.9550
8,051.1240
Operating Income
-2,271.3910
-2,412.0420
-5,241.9910
-6,019.9550
-8,051.1240
Net Non Operating Interest Income Expense
1.2080
1.3680
2.0970
2.0780
11.9270
Other Income Expense
--
1,907.6920
-1,541.3060
-36.4790
305.1170
Pretax Income
-362.4910
-502.9820
-6,781.2000
-6,054.3560
-7,734.0800
Net Income Common Stockholders
-362.4910
-502.9820
-6,781.2000
-6,054.3560
-7,734.0800
Diluted NI Available to Com Stockholders
-362.4910
-502.9820
-6,781.2000
-6,054.3560
-7,734.0800
Basic EPS
-0.01
-0.03
-0.45
-0.87
-1.04
Diluted EPS
-0.01
-0.03
-0.45
-0.87
-1.04
Basic Average Shares
22,929.2960
20,047.9900
15,147.3650
6,952.5390
7,436.3410
Diluted Average Shares
22,929.2960
20,047.9900
15,147.3650
6,952.5390
7,436.3410
Total Expenses
2,271.3910
2,412.0420
5,241.9910
6,019.9550
8,051.1240
Net Income from Continuing & Discontinued Operation
-362.4910
-502.9820
-6,781.2000
-6,054.3560
-7,734.0800
Normalized Income
-607.9520
-748.4430
-5,239.8940
-6,017.8770
-7,734.0800
Interest Income
1.2080
1.3680
2.0970
2.0780
11.9270
Net Interest Income
1.2080
1.3680
2.0970
2.0780
11.9270
EBIT
-2,271.3910
-2,412.0420
-5,241.9910
-6,019.9550
-8,051.1240
EBITDA
-2,246.6970
-2,385.4800
-5,191.5930
-5,985.0190
-8,051.1240
Reconciled Depreciation
24.6940
26.5620
50.3980
34.9360
--
Net Income from Continuing Operation Net Minority Interest
-362.4910
-502.9820
-6,781.2000
-6,054.3560
-7,734.0800
Total Unusual Items Excluding Goodwill
245.4610
245.4610
-1,541.3060
-36.4790
--
Total Unusual Items
245.4610
245.4610
-1,541.3060
-36.4790
--
Normalized EBITDA
-2,492.1580
-2,630.9410
-3,650.2870
-5,948.5400
-8,051.1240
8/31/2021 - 3/11/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ANUA.BE XORTX Therapeutics Inc
0.7880
-1.75%
 
ANUA.F XORTX Therapeutics Inc.
0.7120
-2.47%
 
XRTX.V XORTX Therapeutics Inc.
1.3400
+8.06%
 
CMND Clearmind Medicine Inc.
0.9578
+3.97%
 
RGRX RegeneRx Biopharmaceuticals, Inc.
0.0002
0.00%
 
ARTH Arch Therapeutics, Inc.
0.2000
0.00%
 
RGBP Regen BioPharma, Inc.
0.0501
0.00%
 
PMN ProMIS Neurosciences, Inc.
0.6200
-0.06%
 
XRTX XORTX Therapeutics Inc.
0.9390
+6.70%
 
LSTA Lisata Therapeutics, Inc.
2.1600
+0.47%